Appendix 4D, Half-year report of 30th June, 2019, has been lodged with the Australian Securities Exchange.
View Appendix 4D Half-year report.
Imagion Appoints New Non-Executive Director, Brett Mitchell
MELBOURNE – Imagion Biosystems (ASX:IBX), a company dedicated to improving healthcare through the early detection of cancer, today announced the appointment of Mr Brett Mitchell